Innate Pharma SA Selling, General and Administrative Expense
Innate Pharma SA (IPHA) reported Selling, General and Administrative Expense of EUR 19.72 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2025-04-30
| Period end | Selling General And Administrative Expense 6 month | Selling General And Administrative Expense 12 month | Selling General And Administrative Expense 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | 19.72M EUR 20-F · filed 2025-04-30 | ||
| 2023-12-31 | 18.29M EUR 20-F · filed 2025-04-30 | ||
| 2022-12-31 | 22.44M EUR 20-F · filed 2025-04-30 | ||
| 2021-12-31 | 25.52M EUR 20-F · filed 2024-04-04 | ||
| 2021-06-30 | 19.32M EUR 6-K · filed 2021-09-15 | ||
| 2020-12-31 | 18.99M EUR 20-F · filed 2023-04-06 | 31.25M EUR 20-F · filed 2021-04-27 | |
| 2020-06-30 | 14.49M EUR 6-K · filed 2021-09-15 | ||
| 2019-12-31 | 20.98M EUR 20-F · filed 2022-04-04 | 25.80M EUR 20-F · filed 2020-04-24 | |
| 2018-12-31 | 18.14M EUR 20-F · filed 2021-04-27 | ||
| 2017-12-31 | 17.02M EUR 20-F · filed 2020-04-24 |